Original Research
Published on 23 Sep 2022
Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia
in Cancer Immunity and Immunotherapy

- 1,966 views
- 3 citations
Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Review
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Mini Review
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Review
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Review
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Sep 2022
in Cancer Immunity and Immunotherapy
